29 reports

  • Introduction
  • ANGINA PECTORIS MARKET IN APAC

Ramipril is one of the major angiotensin-converting enzyme inhibitors used by patients with angina pectoris.

  • Angina
  • Beta-Blocker
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG

2019 Future of Angina/ Angina Pectoris R& D Pipeline Drugs and Companies- Analysis of Global Angina (Angina Pectoris) Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments ##.

  • Angina
  • Chronic Disease
  • Pathology

Angina (Angina Pectoris) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019 ##.

  • Angina
  • Chronic Disease
  • Pathology
  • Demand
  • Product Initiative
  • Prevalence of angina pectoris, males (000s)
  • TOP-LINE PREVALENCE FOR ANGINA PECTORIS

PLoS One. 2012; ##(##):e## ##.

  • Angina
  • Chronic Disease
  • Pathology

Angina Pectoris Drugs Market Analysis, By Therapeutic Class, By Major Markets And Segment Forecasts, 2016 - 2022 Chapter ## Research Methodology ##. ##.

  • Angina
  • United States
  • Forecast
  • DISEASE DEFINITION
  • NITRATES

Chest pain (angina) TYPES OF ANGINA Angina Stable angina/ Angina pectoris Unstable angina Types of angina Stable angina/ Angina pectoris This is the most common type of angina.

  • Angina
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.
  • TOP COMPANIES PARTICIPATING IN VASOSPASTIC ANGINA THERAPEUTICS CLINICAL TRIALS
  • VASOSPASTIC ANGINA THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2018*

VASOSPASTIC ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* PROMINENT DRUGS VASOSPASTIC ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018* VASOSPASTIC ANGINA THERAPEUTICS CLINICAL TR

  • Angina
  • Cardiovascular Drug
  • Clinical Trial
  • World
  • Product Initiative
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF UNSTABLE ANGINA TO CARDIOVASCULAR CLINICAL TRIALS
  • UNSTABLE ANGINA THERAPEUTICS, GLOBAL, CLINICAL TRIALS IN PROGRESS BY TOP COUNTRIES, 2018*

CLINICAL TRIALS BY PHASE IN G## COUNTRIES UNSTABLE ANGINA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* UNSTABLE ANGINA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* Country Name Phase IV Phase III/ IV Phase III Phase II/ III Phase II Phase I Phas

  • Angina
  • Blood Disease
  • Cardiovascular Disease
  • Clinical Trial
  • World
  • TOP COMPANIES PARTICIPATING IN STABLE ANGINA THERAPEUTICS CLINICAL TRIALS
  • STABLE ANGINA THERAPEUTICS MARKET, GLOBAL, CLINICAL TRIALS BY SPONSOR TYPE (%), 2018*

The prominent features of this report are - ##.

  • Angina
  • Cardiovascular Disease
  • Clinical Trial
  • Therapy
  • World
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF REFRACTORY ANGINA TO CARDIOVASCULAR CLINICAL TRIALS
  • TOP COMPANIES PARTICIPATING IN REFRACTORY ANGINA THERAPEUTICS CLINICAL TRIALS

REFRACTORY ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* REFRACTORY ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* REFRACTORY ANGINA THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* Company Name Le

  • Angina
  • Clinical Trial
  • World
  • Product Initiative
  • Les Laboratoires Servier SAS
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CHRONIC STABLE ANGINA TO CARDIOVASCULAR CLINICAL TRIALS
  • CHRONIC STABLE ANGINA THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY PHASE (%), 2017*

CLINICAL TRIALS BY PHASE IN G## COUNTRIES CHRONIC STABLE ANGINA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* CHRONIC STABLE ANGINA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* CHRONIC STABLE ANGINA THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY

  • Angina
  • Therapy
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Dormant Projects

NA : Not Available Source: Global Markets Direct KI-## - DRUG PROFILE NITROGLYCERIN - DRUG PROFILE RANOLAZINE ER - DRUG PROFILE SMALL MOLECULES FOR ANGINA - DRUG PROFILE XC-## - DRUG PROFILE Angina (Angina Pectoris) - Dormant Projects ANGINA (ANGINA PE

  • Angina
  • Cardiology
  • Cardiovascular Disease
  • United States
  • Product Initiative
  • Angina (Angina Pectoris) - Overview
  • Angina (Angina Pectoris) - Dormant Projects

Angina (Angina Pectoris) - Overview Angina (Angina Pectoris) - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ANGINA (ANGINA PECTORIS), H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ANGINA (

  • Angina
  • Cardiovascular Disease
  • Therapy
  • United States
  • Product Initiative

The report focuses on drugs and therapies being evaluated for Angina (Angina Pectoris) treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Pathology

Insights into Angina (Angina Pectoris) Pipeline ##.

  • Angina
  • Chronic Disease
  • Pathology
  • World

The report focuses on drugs and therapies being evaluated for Vasospastic Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology

The report focuses on drugs and therapies being evaluated for Unstable Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development

The report focuses on drugs and therapies being evaluated for Stable Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development

The report focuses on drugs and therapies being evaluated for Refractory Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology

The report focuses on drugs and therapies being evaluated for Chronic Stable Angina treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development

Angina (Angina Pectoris) - Pipeline Insight, 2019 ##.

  • Angina
  • Chronic Disease
  • Pathology
  • Chronic Stable Angina Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Chronic Stable Angina Therapeutics Clinical Trials, Central and South America, Top Countries, 2016*

The prominent features of this report are - ##.

  • Angina
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative

2019 Vasospastic Angina Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • APAC

2019 Unstable Angina Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • APAC

2019 Stable Angina Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • APAC

2019 Refractory Angina Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • APAC

2019 Chronic Stable Angina Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Angina
  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • APAC
  • Refractory Angina Therapeutics, Global, Clinical Trials by Trial Status, 2016*
  • Refractory Angina Therapeutics Clinical Trials, Global, Key Sponsors, 2016*

Refractory Angina Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* Refractory Angina Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* Refractory Angina Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* Company Name Ph

  • Angina
  • Chronic Disease
  • Pathology
  • World
  • Product Initiative

2018 Angina Pectoris Or Ischemic Chest Pain Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Angina Pectoris Or Ischemic Chest Pain Market ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Angina Pecto

  • Angina
  • Chronic Disease
  • Pathology